
Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.
Bryan Wilson, executive director of medical affairs at Genentech, details why Birmingham, Alabama was chosen as the community to study the effects of diabetic eye disease among African Americans in a new manuscript from the ADA and Genentech.
The manuscript, "Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama," highlights the burden of diabetic eye disease in Alabama, as well as strategies that target racial health disparities within that population.
Jill Saxon, OD, FAAO, chats about eye health safety for the upcoming total solar eclipse on April 8, 2024, and how Bausch + Lomb is celebrating the celestial event.
Davis Corley, CEO of Neurolens, outlines the importance a new study that show statistically significant improvement of headaches with the use of Neurolens.
Charles Leclercq, CEO of ARxVision, outlines the conception of ARxVIsion's collaboration with Seeing AI and NaviLens apps, and details the popular uses for the headset so far.
Rebecca Alexander, LCSW-R, MPH, has been gradually losing both her vision and hearing since she was a teenager due to Usher syndrome type 3. She discusses the importance of making practice accessible for those with vision loss in an exclusive interview.
Ben Gaddie, OD, FAAO closes this series discussing his treatment protocol for patients with demodex blepharitis, reflecting on the major treatment advancements that can quickly alleviate patient symptoms.
Ben Gaddie, OD, FAAO presents the second patient case of a 66-year-old white female with eye dryness and irritation. Though she was not previously treated for demodex blepharitis, he demonstrates how it was the root cause of many symptoms she experienced.
Ben Gaddie, OD, FAAO discusses demodex blepharitis, common symptoms, and prior treatment options that struggled to control their reproductive cycle.
Ben Gaddie, OD, FAAO presents the first patient case of a 53-year-old white female who has tried many treatments. Gaddie highlights his treatment approach and how the patient saw improvements within eight weeks.
March 23 is World Optometry Day, and we asked members of the optometric community one question: How does optometry make the world a better place?
With The Ohio State University College of Optometry in the path of totality for this year's total solar eclipse, 1 optometry school has prepared its alumni, students, and doctors to share information with the public.
Nicholas Gilberg, OD, with EssilorLuxxotica's Leonardo team walks through the basics of the education software that can be implemented in any practice.
Laura Periman, MD, talks through what was gained from the conference, from becoming acquainted with new technological advancements to renewing passion for dry eye care.
Optometrists are often the first to notice ocular adverse effects from systemic medication. When should optometrists reach out to prescribing doctors?
Scott Moscow, OD, talks his practice's contact lens "test-driving" option and how to get patients on board with trying out new corrective eyewear.
At Vision Expo East 2024, Srinivas Kondapalli, MD, demonstrates how to use Rinsada to address ocular surface disease.
Alysse Henkel, vice president of research and inSights at The Vision Council, details recent research conducted by the company regarding consumer purchasing habits and trends.
Mile Brujic, OD, FAAO, speaks on the power of Rinsada to bust biofilms at Vision Expo East 2024.
Dr Brianna Rhue, OD, FAAO, FSLS details her upcoming presentation "Cutting Out Surgery for the Management of Refractive Error," where she will detail the underutilization of orthokeratology during Vision Expo East 2024 later this week.
Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them.
The Vision Council's CEO Ashley Mills previews a nostalgic year for Vision Expo East, as it celebrates and looks back on almost 40 years in New York.
Marc R Bloomenstein, OD, FAAO, chats with Optometry Times on the benefits of using Vevye to treat dry eye disease, when to prescribe, and how to distinguish quality candidates.
Eric Fazio, OD, sits down with Optometry Times to weigh the pros and cons of EVO ICLs and LASIK and the role comanagement plays in the decision.
Barry Eiden, OD, FAAO, FSLS, sits down with Optometry Times to highlight the importance of staying up-to-date with technology in the development of treatment and diagnosis of keratoconus and what's to come at this year's IKA Keratoconus Symposium in May.
R Tracy Williams, OD, FAAO, reflects on his favorite stories working as a team optometrist for the Chicago Bulls and Chicago White Sox in the last 20 years.
R Tracy Williams, OD, FAAO, has been team optometrist for the Chicago Bulls and White Sox for over 20 years. He details how treatment of professional athletes is different than the general public in an exclusive interview with Optometry Times.
Neda Shamie, MD, delves into the evolution of the Controversies in Modern Eye Care meeting, while highlighting what distinguishes it from other conferences.
Andrew S. Morgenstern, OD, FAAO, FNAP sits down with Optometry Times to reiterate under-utilized diagnostic tools for keratoconus and the planning of this year's International Keratoconus Academy Keratoconus Symposium, running from May 18-19 in Bethesda, Maryland.